Clinical Trials Directory

Trials / Unknown

UnknownNCT01703130

Determining the Minimal Effective Volume (MEAV95) for Interscalene Brachial Plexus Block for Surgical Anesthesia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
60 (estimated)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Interscalene block (ISB) consistently demonstrates superior pain relief after shoulder surgery. However, patients can experience complications such as blurred vision, hoarseness and shortness of breath with the standard volumes of local anesthetic used in contemporary practice. Patients with respiratory diseases are precluded because of the potential effects on respiration. However, they are then exposed to the risks of general anesthesia and opioid medications which can also have detrimental effects on respiration. Ultrasound guided ISB can reduce the local anesthetic volume required to produce anesthesia for shoulder surgery; this may reduce the complications from ISB to allow patients previously unable to benefit to have this technique, such as patients with obesity and respiratory disease. In order to do so the investigators will use an up-down methodology to find the minimum volume of local anesthetic to provide sufficient anesthesia for shoulder surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREDose of of ropivacaine 0.75% used in block procedure

Timeline

Start date
2012-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2012-10-10
Last updated
2014-06-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01703130. Inclusion in this directory is not an endorsement.